TY  - GEN
AU  - Wang,Victoria E
AU  - Xue,Jenny Y
AU  - Frederick,Dennie T
AU  - Cao,Yi
AU  - Lin,Eva
AU  - Wilson,Catherine
AU  - Urisman,Anatoly
AU  - Carbone,David P
AU  - Flaherty,Keith T
AU  - Bernards,Rene
AU  - Lito,Piro
AU  - Settleman,Jeff
AU  - McCormick,Frank
TI  - Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation
SN  - 1557-3265
PY  - 2020///0921
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - Autocrine Communication
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cell Proliferation
KW  - Drug Resistance, Neoplasm
KW  - Fibroblast Growth Factor 1
KW  - Gene Expression Regulation, Neoplastic
KW  - High-Throughput Screening Assays
KW  - Humans
KW  - Lung Neoplasms
KW  - MAP Kinase Kinase 1
KW  - antagonists & inhibitors
KW  - Melanoma
KW  - Mice
KW  - Mice, Nude
KW  - Prognosis
KW  - Proto-Oncogene Proteins B-raf
KW  - Receptor, Fibroblast Growth Factor, Type 1
KW  - Survival Rate
KW  - Tumor Cells, Cultured
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1158/1078-0432.CCR-18-2779
ER  -